Downregulation of Sox9 expression associates with hepatogenic differentiation of human liver mesenchymal stem/progenitor cells

Stem Cells and Development

Volumn 23, Issue 12, 2014, Pages 1377-1391

  Paganelli, Massimiliano ^a   Nyabi, Omar ^a   Sid, Brice ^a   Evraerts, Jonathan ^a   El Malmi, Imane ^a   Heremans, Yves ^b   Dollé, Laurent ^c   Benton, Carley ^a   Calderon, Pedro Buc ^a   Van Grunsven, Leo ^c   Heimberg, Harry ^b,d   Campard, David ^a   Sokal, Etienne ^a   Najimi, Mustapha ^a  

^a UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^b DIABETES RESEARCH CENTER   (Belgium)

^c VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

^d VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME P450 3A; GLUCOSE 6 PHOSPHATASE; MESSENGER RNA; ONCOSTATIN M; SHORT HAIRPIN RNA; TRANSCRIPTION FACTOR SOX9; TRANSFORMING GROWTH FACTOR BETA; SOX9 PROTEIN, HUMAN;

ADULT STEM CELL; ARTICLE; CELL DIFFERENTIATION; CELL LINEAGE; CELL MATURATION; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVITY; GENE EXPRESSION; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOCYTOCHEMISTRY; IMMUNOHISTOCHEMISTRY; LIVER CELL; MESENCHYMAL STEM CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; BIOSYNTHESIS; CELL PROLIFERATION; CYTOLOGY; GENE EXPRESSION REGULATION; GENETICS; HEPG2 CELL LINE; MESENCHYMAL STROMA CELL; METABOLISM;

CELL DIFFERENTIATION; CELL PROLIFERATION; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HEP G2 CELLS; HEPATOCYTES; HUMANS; MESENCHYMAL STROMAL CELLS; RNA, MESSENGER; SOX9 TRANSCRIPTION FACTOR; TRANSFORMING GROWTH FACTOR BETA;

EID: 84902130533     PISSN: 15473287     EISSN: 15578534     Source Type: Journal    
DOI: 10.1089/scd.2013.0169     Document Type: Article

References (56)

1. Si-Tayeb K, FP Lemaigre and SA Duncan. (2010). Organogenesis and development of the liver. Dev Cell 18:175-189.
2. Gualdi R, P Bossard, M Zheng, Y Hamada, JR Coleman and KS Zaret. (1996). Hepatic specification of the gut endoderm in vitro: cell signaling and transcriptional control. Genes Dev 10:1670-1682.
3. Jung J, M Zheng, M Goldfarb and KS Zaret. (1999). Initiation of mammalian liver development from endoderm by fibroblast growth factors. Science 284:1998-2003.
4. Zaret KS. (2008). Genetic programming of liver and pancreas progenitors: lessons for stem-cell differentiation. Nat Rev Genet 9:329-340.
5. Breuhahn K, T Longerich and P Schirmacher. (2006). Dysregulation of growth factor signaling in human hepatocellular carcinoma. Oncogene 25:3787-3800.
6. Deli A, E Kreidl, S Santifaller, B Trotter, K Seir, W Berger, R Schulte-Hermann, C Rodgarkia-Dara and M Grusch. (2008). Activins and activin antagonists in hepatocellular carcinoma. World J Gastroenterol 14:1699-1709.
7. Tanimizu N and A Miyajima. (2007). Molecular mechanism of liver development and regeneration. Int Rev Cytol 259:1-48.
8. Massague J and DWotton. (2000). Transcriptional control by theTGF-beta/Smadsignalingsystem.EMBOJ19:1745-1754.
9. Shi Y and J Massague. (2003). Mechanisms of TGF-beta signaling from cell membrane to the nucleus. Cell 113:685-700.
10. Clotman F and FP Lemaigre. (2006). Control of hepatic differentiation by activin/TGFbeta signaling. Cell Cycle 5:168-171.
11. Herrera B, AM Alvarez, J Beltran, F Valdes, I Fabregat and M Fernandez. (2004). Resistance to TGF-beta-induced apoptosis in regenerating hepatocytes. J Cell Physiol 201: 385-392.
12. Thenappan A, Y Li, K Kitisin, A Rashid, K Shetty, L Johnson and L Mishra. (2010). Role of transforming growth factor beta signaling and expansion of progenitor cells in regenerating liver. Hepatology 51:1373-1382.
13. Goumans MJ, A Zwijsen, MA van Rooijen, D Huylebroeck, BA Roelen and CL Mummery. (1999). Transforming growth factor-beta signalling in extraembryonic mesoderm is required for yolk sac vasculogenesis in mice. Development 126:3473-3483.
14. Miyazono K. (2000). Positive and negative regulation of TGF-beta signaling. J Cell Sci 113 (Pt 7):1101-1109.
15. Akiyama H. (2008). Control of chondrogenesis by the transcription factor Sox9. Mod Rheumatol 18:213-219.
16. Wright E, MR Hargrave, J Christiansen, L Cooper, J Kun, T Evans, U Gangadharan, A Greenfield and P Koopman. (1995). The Sry-related gene Sox9 is expressed during chondrogenesis in mouse embryos. Nat Genet 9:15-20.
17. Mori-Akiyama Y, M van den Born, JH van Es, SR Hamilton, HP Adams, J Zhang, H Clevers and B de Crombrugghe. (2007). SOX9 is required for the differentiation of paneth cells in the intestinal epithelium. Gastroenterology 133:539-546.
18. Seymour PA, KK Freude, MN Tran, EE Mayes, J Jensen, R Kist, G Scherer and M Sander. (2007). SOX9 is required for maintenance of the pancreatic progenitor cell pool. Proc Natl Acad Sci U S A 104:1865-1870.
19. Jiang SS, WT Fang, YH Hou, SF Huang, BL Yen, JL Chang, SM Li, HP Liu, YL Liu, et al. (2010). Upregulation of SOX9 in lung adenocarcinoma and its involvement in the regulation of cell growth and tumorigenicity. Clin Cancer Res 16:4363-4373.
20. Afonja O, BM Raaka, A Huang, S Das, X Zhao, E Helmer, D Juste and HH Samuels. (2002). RAR agonists stimulate SOX9 gene expression in breast cancer cell lines: evidence for a role in retinoid-mediated growth inhibition. Oncogene 21:7850-7860.
21. Sashikawa Kimura M, H Mutoh and K Sugano. (2011). SOX9 is expressed in normal stomach, intestinal metaplasia, and gastric carcinoma in humans. J Gastroenterol 46: 1292-1299.
22. Guo X, L Xiong, T Sun, R Peng, L Zou, H Zhu, J Zhang, H Li and J Zhao. (2012). Expression features of SOX9 associate with tumor progression and poor prognosis of hepatocellular carcinoma. Diagn Pathol 7:44.
23. Chimal-Monroy J, J Rodriguez-Leon, JA Montero, Y Gan an, D Macias, R Merino and JM Hurle. (2003). Analysis of the molecular cascade responsible for mesodermal limb chondrogenesis: Sox genes and BMP signaling. Dev Biol 257:292-301.
24. Kawakami Y, J Rodriguez-Leon and JC Izpisua Belmonte. (2006). The role of TGFbetas and Sox9 during limb chondrogenesis. Curr Opin Cell Biol 18:723-729.
25. Hanley KP, F Oakley, S Sugden, DI Wilson, DA Mann and NA Hanley. (2008). Ectopic SOX9 mediates extracellular matrix deposition characteristic of organ fibrosis. J Biol Chem 283:14063-14071.
26. Furuyama K, Y Kawaguchi, H Akiyama, M Horiguchi, S Kodama, T Kuhara, S Hosokawa, A Elbahrawy, T Soeda, et al. (2011). Continuous cell supply from a Sox9-expressing progenitor zone in adult liver, exocrine pancreas and intestine. Nat Genet 43:34-41.
27. Campard D, PA Lysy, M Najimi and EM Sokal. (2008). Native umbilical cord matrix stem cells express hepatic markers and differentiate into hepatocyte-like cells. Gastroenterology 134:833-848.
28. Najimi M, DN Khuu, PA Lysy, N Jazouli, J Abarca, C Sempoux and EM Sokal. (2007). Adult-derived human liver mesenchymal-like cells as a potential progenitor reservoir of hepatocytes? Cell Transplant 16:717-728.
29. Lee KD, TK Kuo, J Whang-Peng, YF Chung, CT Lin, SH Chou, JE Chen, YP Chen and OK Lee. (2004). In vitro hepatic differentiation of human mesenchymal stem cells. Hepatology 40:1275-1284.
30. Antoniou A, P Raynaud, S Cordi, Y Zong, F Tronche, BZ Stanger, P Jacquemin, CE Pierreux, F Clotman and FP Lemaigre. (2009). Intrahepatic bile ducts develop according to a new mode of tubulogenesis regulated by the transcription factor SOX9. Gastroenterology 136:2325-2333.
31. Stephenne X, M Najimi, F Smets, R Reding, J de Ville de Goyet and EM Sokal. (2005). Cryopreserved liver cell transplantation controls ornithine transcarbamylase deficient patient while waiting liver transplantation. Am J Transplant 5:2058-2061.
32. Lysy P, D Campard, F Smets, J Malaise, M Mourad, M Najimi and EM Sokal. (2008). Persistence of a chimerical phenotype after hepatocyte differentiation of human bone marrow mesenchymal stem cells. Cell Proliferat 41:36-58.
33. Khuu DN, I Scheers, S Ehnert, N Jazouli, O Nyabi, P Buc-Calderon, A Meulemans, A Nussler, EM Sokal and M Najimi. In vitro differentiated adult human liver progenitor cells display mature hepatic metabolic functions: a potential tool for in vitro pharmaco-toxicological testing. Cell Transplant 20:287-302.
34. Naldini L, U Blomer, P Gallay, D Ory, R Mulligan, FH Gage, IM Verma and D Trono. (1996). In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science 272:263-267.
35. Scherr M, K Battmer, U Blomer, A Ganser and M Grez. (2001). Quantitative determination of lentiviral vector particle numbers by real-time PCR. Biotechniques 31:520, 522, 524.
36. Germain L, MJ Blouin and N Marceau. (1988). Biliary epithelial and hepatocytic cell lineage relationships in embryonic rat liver as determined by the differential expression of cytokeratins, alpha-fetoprotein, albumin, and cell surface-exposed components. Cancer Res 48:4909-4918.
37. Roskams T. (2008). Relationships among stellate cell activation, progenitor cells, and hepatic regeneration. Clin Liver Dis 12:853-860.
38. Shiojiri N. (1997). Development and differentiation of bile ducts in the mammalian liver. Microsc Res Tech 39:328-335.
39. Chaboissier MC, A Kobayashi, VI Vidal, S Lutzkendorf, HJ van de Kant, M Wegner, DG de Rooij, RR Behringer and A Schedl. (2004). Functional analysis of Sox8 and Sox9 during sex determination in the mouse. Development 131:1891-1901.
40. Poche RA, Y Furuta, MC Chaboissier, A Schedl and RR Behringer. (2008). Sox9 is expressed in mouse multipotent retinal progenitor cells and functions in Muller glial cell development. J Comp Neurol 510:237-250.
41. Stolt CC, P Lommes, E Sock, MC Chaboissier, A Schedl and M Wegner. (2003). The Sox9 transcription factor determines glial fate choice in the developing spinal cord. Genes Dev 17:1677-1689.
42. Vidal VP, MC Chaboissier, S Lutzkendorf, G Cotsarelis, P Mill, CC Hui, N Ortonne, JP Ortonne and A Schedl. (2005). Sox9 is essential for outer root sheath differentiation and the formation of the hair stem cell compartment. Curr Biol 15:1340-1345.
43. Fu N, I Drinnenberg, J Kelso, JR Wu, S Paabo, R Zeng and P Khaitovich. (2007). Comparison of protein and mRNA expression evolution in humans and chimpanzees. PLoS One 2:e216.
44. Caron MM, PJ Emans, MM Coolsen, L Voss, DA Surtel, A Cremers, LW van Rhijn and TJ Welting. (2012). Redifferentiation of dedifferentiated human articular chondrocytes: comparison of 2D and 3D cultures. Osteoarthr Cartilage 20:1170-1178.
45. Chiou M, Y Xu and MT Longaker. (2006). Mitogenic and chondrogenic effects of fibroblast growth factor-2 in adipose-derived mesenchymal cells. Biochem Biophys Res Commun 343:644-652.
46. Grano M, F Galimi, G Zambonin, S Colucci, E Cottone, AZ Zallone and PM Comoglio. (1996). Hepatocyte growth factor is a coupling factor for osteoclasts and osteoblasts in vitro. Proc Natl Acad Sci U S A 93:7644-7648.
47. D'Ippolito G, PC Schiller, C Perez-stable, W Balkan, BA Roos and GA Howard. (2002). Cooperative actions of hepatocyte growth factor and 1,25-dihydroxyvitamin D3 in osteoblastic differentiation of human vertebral bone marrow stromal cells. Bone 31:269-275.
48. Grumbles RM, DS Howell, L Wenger, RD Altman, GA Howard and BA Roos. (1996). Hepatocyte growth factor and its actions in growth plate chondrocytes. Bone 19:255-261.
49. Baek WY and JE Kim. (2011). Transcriptional regulation of bone formation. Front Biosci (Schol Ed) 3:126-135.
50. Legendre F, J Dudhia, JP Pujol and P Bogdanowicz. (2003). JAK/STAT but not ERK1/ERK2 pathway mediates interleukin (IL)-6/soluble IL-6R down-regulation of Type II collagen, aggrecan core, and link protein transcription in articular chondrocytes. Association with a down-regulation of SOX9 expression. J Biol Chem 278:29003-29012.
51. Stockl S, RJ Bauer, AK Bosserhoff, C Gottl, J Grifka and S Grassel. (2013). Sox9 modulates cell survival and adipogenic differentiation of multipotent adult rat mesenchymal stem cells. J Cell Sci 126(Pt 13):2890-2902.
52. Matheu A, M Collado, C Wise, L Manterola, L Cekaite, AJ Tye, M Canamero, L Bujanda, A Schedl, et al. (2012). Oncogenicity of the developmental transcription factor Sox9. Cancer Res 72:1301-1315.
53. Bellido T, CA O'Brien, PK Roberson and SC Manolagas. (1998). Transcriptional activation of the p21(WAF1,-CIP1,SDI1) gene by interleukin-6 type cytokines. A prerequisite for their pro-differentiating and anti-apoptotic effects on human osteoblastic cells. J Biol Chem 273:21137-21144.
54. Clotman F, P Jacquemin, N Plumb-Rudewiez, CE Pierreux, P Van der Smissen, HC Dietz, PJ Courtoy, GG Rousseau and FP Lemaigre. (2005). Control of liver cell fate decision by a gradient of TGF beta signaling modulated by Onecut transcription factors. Genes Dev 19:1849-1854.
55. Akkari L, D Haouzi, F Biname, N Floc'h, P Lassus, S Baghdiguian and U Hibner. (2010). Cell shape and TGFbeta signaling define the choice of lineage during in vitro differentiation of mouse primary hepatic precursors. J Cell Physiol 225:186-195.
56. Bhandari RK, MM Haque and MK Skinner. (2012). Global genome analysis of the downstream binding targets of testis determining factor SRY and SOX9. PLoS One 7:e43380.